Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Danderyd – page 45

771 clinical trials in Danderyd, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Danderyd at a glance
771
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

771 trials in Danderyd

Open in trial search

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Study of Latozinemab for Patients with Neurodegenerative Diseases Who Previously Participated in a Latozinemab Study

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Latozinemab
  • Sponsor:Alector LLC

Emphysema

Not recruiting

Study on Long-term Safety of Weekly Intravenous Alpha-1-Proteinase Inhibitor for Patients with Pulmonary Emphysema Due to Alpha-1-Antitrypsin Deficiency

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:ALPHA-1-ANTITRYPSIN
  • Sponsor:Grifols Therapeutics LLC

Emphysema

Not recruiting

Study on the Effects of Alpha-1-Proteinase Inhibitor for Patients with Pulmonary Emphysema Due to Alpha-1 Antitrypsin Deficiency

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:ALPHA-1-ANTITRYPSIN
  • Sponsor:Grifols Therapeutics LLC

Demyelination

Not recruiting

Study on the Effectiveness and Safety of Rozanolixizumab for Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOG-AD)

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Rozanolixizumab
  • Sponsor:UCB Biopharma

Cholangiocarcinoma

Not recruiting

Study Comparing Pemigatinib and Gemcitabine Plus Cisplatin for First-Line Treatment in Patients with Unresectable or Metastatic Cholangiocarcinoma with FGFR2 Rearrangement

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Incyte Corp.

Schizophrenia

Not recruiting

Study on Rituximab for Adults with Schizophrenia Spectrum Disorder

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Rituximab
  • Sponsor:Region Oerebro Laen

Study on the Effects of AZD3427 on Kidney Function in Heart Failure Patients with Kidney Issues

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:AZD3427
  • Sponsor:AstraZeneca AB

Study on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:BI 1819479
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on the Safety and Effectiveness of BOOST Cells for Treating Severe Osteogenesis Imperfecta in Children Before and After Birth

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Allogeneic Fetal Mesenchymal Stem Cells
  • Sponsor:Karolinska Institutet

Study on Vaginal Tamoxifen for Improving Sexual Function in Women with Breast Cancer Experiencing Vulvovaginal Atrophy Symptoms

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Tamoxifen Citrate
  • Sponsor:Uppsala University

Comparison of dapagliflozin versus metformin treatment in patients with early stage type 2 diabetes to evaluate survival and complications

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin Propanediol
  • Sponsor:Uppsala University

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Danderyd

What the registry says about research in the country

01 Cardiovascular and Renal Studies

Innovative research focusing on chronic kidney disease treatments and cardiovascular conditions, including trials examining new therapeutic combinations for heart failure and blood pressure management.

  • Hypertension management in CKD patients
  • Heart failure with preserved ejection fraction
  • Left ventricular thrombosis treatments

Multiple studies are evaluating novel drug combinations and their impact on patient outcomes.

02 Gastrointestinal Research

Comprehensive studies on inflammatory bowel conditions, with particular focus on Crohn's Disease and Ulcerative Colitis treatments using innovative biological therapies.

  • Novel therapeutic combinations for IBD
  • Primary sclerosing cholangitis treatments
  • Colorectal cancer interventions

Research aims to improve treatment outcomes and quality of life for patients with chronic gastrointestinal conditions.

03 Women's Health Studies

Advanced research in women's health, including studies on hormonal contraception, menopause management, and reproductive health conditions.

  • Brain effects of contraceptives
  • Treatment for menstrual pain
  • Menopausal hormone therapy safety

These trials focus on developing safer and more effective treatments for women's health concerns.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.